SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

@article{RinaldiCarmona1994SR141716AAP,
  title={SR141716A, a potent and selective antagonist of the brain cannabinoid receptor},
  author={Murielle Rinaldi-Carmona and Francis Barth and Michel H{\'e}aulme and David Shire and Bernard Calandra and Christian Congy and Serge Martinez and Jean Maruani and Gervais N{\'e}liat and Daniel Caput and Pascual Ferrara and Philippe Soubrié and Jean Claude Breliere and Gérard Le Fur},
  journal={FEBS Letters},
  year={1994},
  volume={350}
}
View on Wiley
ncbi.nlm.nih.gov
1,750 Citations
Highly Influential Citations
121
Background Citations
499
Methods Citations
88
Results Citations
27

1,750 Citations

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.
SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice.
Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.
The therapeutic applications of cannabinoid agonists and antagonists
TLDR
Antagonists have now also been described for both receptor subtypes, which are involved in analgesia, cognition, memory, locomotor activity, control of appetite and vomiting, regulation of intestinal, bronchial and uterine contraction, and control of intra-ocular pressure.
Pharmacology of cannabinoid CB1 and CB2 receptors.
  • R. Pertwee
  • Biology, Medicine
    Pharmacology & therapeutics
  • 1997
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
TLDR
These results suggest for the first time that endogenous cannabinoid systems may modulate the appetitive value of sucrose and ethanol, perhaps by affecting the activity of brain reward systems.
New cannabinoid receptor antagonists as pharmacological tool.
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
TLDR
It is expected that SR 144528 will provide a powerful tool to investigate the in vivo functions of the cannabinoid system in the immune response.
SR147778, A NEW POTENT AND SELECTIVE ANTAGONIST OF THE CB1 CANNABINOID RECEPTOR. BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION
TLDR
SR147778 is introduced as a highly potent, selective and orally active antagonist for the CB1 receptor, which is able to reduce both ethanol or sucrose consumption in mice and rats and food intake in fasted and non-deprived rats.
Effect of opioid and cannabinoid receptor antagonism on orphanin FQ-induced hyperphagia in rats.
...
...

References

SHOWING 1-10 OF 24 REFERENCES
Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
Arachidonylethanolamide, an arachidonic acid derivative in porcine brain, was identified in a screen for endogenous ligands for the cannabinoid receptor. The structure of this compound, which has…
Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model.
TLDR
It is postulated that the receptor that is associated with the regulation of adenylate cyclase in vitro may be the same receptor as that mediating analgesia in vivo, and a conceptualization of the cannabinoid analgetic receptor is presented.
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
TLDR
The cloning and expression of a complementary DNA that encodes a G protein-coupled receptor that is involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana are suggested.
Molecular characterization of a peripheral receptor for cannabinoids
TLDR
The cloning of a receptor for cannabinoids is reported that is not expressed in the brain but rather in macrophages in the marginal zone of spleen, which helps clarify the non-psychoactive effects of cannabinoids.
Aminoalkylindoles: actions on specific G-protein-linked receptors.
TLDR
The results suggest that AAIs bind to specific receptors which are coupled through G-proteins to inhibit adenylyl cyclase, which is similar to how serotonin binds to guanine nucleotides in humans.
Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.
TLDR
St stereoselective immune modulation was observed with the synthetic bicyclic cannabinoid (-)-CP-55,940 versus (+) CP-56,667 and with 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl and the (-)-enantiomer demonstrated greater immunoinhibitory potency than the (+)-isomer, as measured by the in vitro sheep red blood cell antibody-forming cell response.
Pravadoline: profile in isolated tissue preparations.
TLDR
It is concluded that pravadoline and aminoalkylinodole analogs are inhibitory in several bioassay systems via a presynaptic mechanism which does not involve inhibition of cyclooxygenase, or the activation or inhibition of several known receptors.
Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones.
TLDR
Binding constants measured using CP55,940 indicated that the rat and human cloned cannabinoid receptors were similar to native cannabinoid receptors measured in brain and neural cell lines, and cannabinoid agonists can stimulate signaling pathways through both receptor- and non-receptor-mediated pathways in the same cell.
Cannabinoid-receptor expression in human leukocytes.
TLDR
The demonstration of cannabinoid-receptor expression at both mRNA and protein levels on human leukocytes provides a molecular basis for cannabinoid action on these cells.
Cannabinoid Receptors and Modulation of Cyclic AMP Accumulation in the Rat Brain
TLDR
The modulation of cyclic AMP accumulation by desacetyllevonantradol could be attenuated following stereotaxic implantation of pertussis toxin, supporting the involvement of a G protein in the cannabinoid response in the brain.
...
...